tiprankstipranks
Trending News
More News >

NuCana CEO Takes Leave Amid Nasdaq Delisting Concerns

Story Highlights
NuCana CEO Takes Leave Amid Nasdaq Delisting Concerns

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Nucana ( (NCNA) ).

On June 18, 2025, NuCana plc announced that its CEO, Hugh S. Griffith, will take a leave of absence due to health reasons, with Andrew Kay stepping in as Executive Chairman and Ian Webster as Interim CFO. Additionally, the company faces potential delisting from the Nasdaq Capital Market due to concerns over its recent May 2025 offering, which could negatively impact its ability to raise capital and the liquidity of its shares.

The most recent analyst rating on (NCNA) stock is a Buy with a $150.00 price target. To see the full list of analyst forecasts on Nucana stock, see the NCNA Stock Forecast page.

Spark’s Take on NCNA Stock

According to Spark, TipRanks’ AI Analyst, NCNA is a Underperform.

Nucana’s overall score is primarily impacted by its financial instability and negative valuation metrics. The significant lack of revenue generation and operational losses are major concerns. Despite showing strong cash management and low leverage, the company’s technical indicators suggest a bearish trend, further weighing down the score. The poor valuation metrics, such as a negative P/E ratio, are offset by potential speculative interest due to the low stock price. The absence of notable earnings call insights or corporate events means these factors did not influence the score.

To see Spark’s full report on NCNA stock, click here.

More about Nucana

NuCana plc is a company operating in the biopharmaceutical industry, primarily focused on developing new cancer treatments. The company is known for its innovative approach to chemotherapy, aiming to improve the efficacy and safety of cancer drugs.

Average Trading Volume: 135,106,728

Technical Sentiment Signal: Sell

Current Market Cap: $794.7K

Find detailed analytics on NCNA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1